When are corticosteroids indicated in myocarditis and what is the recommended dosing regimen for viral versus immune‑mediated forms?

Role of Corticosteroids in Myocarditis

Primary Recommendation

Corticosteroids are contraindicated in typical viral myocarditis and should not be used routinely, as they do not reduce mortality and may reactivate viral infections, perpetuating inflammation rather than resolving it. 1, 2, 3

---

When to AVOID Corticosteroids (Most Common Scenario)

Viral Myocarditis

• The European Society of Cardiology gives a Class III (harm) recommendation against corticosteroids in viral pericarditis/myocarditis due to risk of viral reactivation. 1, 2
• Corticosteroids do not reduce mortality in post-viral myocarditis (RR 0.93,95% CI 0.70-1.24) based on Cochrane systematic review of 719 patients. 4, 5
• NSAIDs and corticosteroids may increase inflammation and mortality in isolated myocarditis without pericardial involvement. 2, 3
• Steroids reactivate many viral infections (including parvovirus B19, herpesviruses, EBV, HHV-6) and lead to ongoing inflammation. 1, 3

What to Do Instead for Viral Myocarditis

• Initiate guideline-directed medical therapy for heart failure: ACE inhibitors/ARBs, beta-blockers (if hemodynamically stable), and aldosterone antagonists. 2, 3
• Enforce strict activity restriction for 3-6 months, as sustained aerobic exercise during acute viral myocarditis increases mortality and sudden death risk. 2, 3
• Provide supportive care with hemodynamic monitoring and arrhythmia management. 3
• Consider mechanical circulatory support (extracorporeal life support) if cardiogenic shock develops despite optimal medical management. 2, 3, 6

---

When to USE Corticosteroids (Specific Immune-Mediated Forms)

1. Immune Checkpoint Inhibitor (ICI)-Related Myocarditis

This is the most critical indication requiring immediate high-dose steroids.

• Initiate emergent high-dose corticosteroids (1 mg/kg methylprednisolone IV) immediately in suspected or confirmed ICI myocarditis. 1, 2, 7
• For grade 3-4 ICI myocarditis: Give methylprednisolone 1 g IV daily for 3-5 consecutive days (pulse phase). 7
• Continue steroids until cardiac function (LVEF) returns to baseline, then taper gradually over 4-6 weeks. 7
• If no clinical improvement within 24 hours, add second-line immunosuppressant (antithymocyte globulin, infliximab, IVIG, or mycophenolate). 7
• Permanently discontinue the immune checkpoint inhibitor for any grade 3 or 4 cardiovascular toxicity. 7

Red flags requiring immediate steroids:

• Troponin ≥1.5 ng/mL (confers ~4-fold increased MACE risk) 7
• New dyspnea, palpitations, chest pain, or syncope in patient on ICI therapy 7
• Hemodynamic instability or cardiogenic shock 7
• BNP >500 pg/mL with new ECG changes (QTc prolongation, conduction disease, ST-T wave changes) 1, 7

2. Giant Cell Myocarditis

• Immunosuppression with corticosteroids is indicated for giant cell myocarditis. 2, 3, 6

3. Cardiac Sarcoidosis

• Immunosuppression with corticosteroids is indicated for cardiac sarcoidosis. 2, 3

4. Eosinophilic Myocarditis

• Corticosteroids are standard treatment for eosinophilic myocarditis. 2, 6

5. Inflammatory Myopathy-Related Myocarditis

• High-dose IV methylprednisolone (10-20 mg/kg) for 1-5 days, followed by oral prednisone 0.5-1 mg/kg/day for 2-4 weeks in combination with a steroid-sparing agent (methotrexate, azathioprine, or mycophenolate mofetil). 7

6. COVID-19-Associated Myocarditis (Specific Scenarios Only)

• Use corticosteroids if patient has both myocarditis AND COVID-19 pneumonia requiring supplemental oxygen. 2
• Consider IV corticosteroids in suspected/confirmed COVID-19 myocarditis with hemodynamic instability or multisystem inflammatory syndrome in adults (MIS-A). 2

7. Pediatric MIS-C (Multisystem Inflammatory Syndrome in Children)

• IVIG (2 gm/kg) and/or glucocorticoids (1-2 mg/kg/day for moderate cases; high-dose IV for shock) are first-tier agents for MIS-C with cardiac involvement. 1
• Taper steroids over 2-3 weeks to avoid rebound inflammation. 1

---

Diagnostic Workup Required Before Steroid Decision

Mandatory Evaluations

• Immediate cardiology consultation and ICU-level monitoring with continuous telemetry. 7
• 12-lead ECG to assess for conduction delays, arrhythmias, or ST-segment changes. 7
• Cardiac biomarkers: troponin (troponin I preferred if skeletal muscle disease present), BNP/NT-proBNP, creatine kinase. 7
• Inflammatory markers: ESR, CRP, white blood cell count. 7
• Cardiac MRI with inflammatory sequences (T2-STIR, T1 mapping, late gadolinium enhancement) is recommended in hemodynamically stable patients for definitive diagnosis. 2, 3, 7
• Consider endomyocardial biopsy with PCR analysis to rule out viral presence before starting immunosuppression, particularly in life-threatening scenarios. 8

Serial Troponin Strategy for ICI Myocarditis

• A single normal troponin does not exclude myocarditis; serial measurements at 3-hour and 6-hour intervals over a 6-10 hour window are required. 7
• Troponin may remain normal for 2-12 hours after symptom onset. 7

---

Common Pitfalls and How to Avoid Them

Pitfall 1: Using Steroids in Typical Viral Myocarditis

• Do not use corticosteroids empirically in acute lymphocytic myocarditis without knowing viral PCR results from endomyocardial biopsy. 8
• Viral reactivation from steroids can perpetuate inflammation and worsen outcomes. 1, 3

Pitfall 2: Delaying Steroids in ICI Myocarditis

• Any delay in starting high-dose steroids for ICI myocarditis markedly worsens outcomes; start at suspicion, not confirmation. 7
• Over 40% of ICI myocarditis cases have co-occurring myositis or myasthenia gravis, which mandates aggressive steroid therapy. 7

Pitfall 3: Premature Steroid Taper

• Early dose reduction can precipitate disease flare; continue steroids until objective cardiac function returns to baseline. 7
• Taper over 4-6 weeks minimum for ICI myocarditis. 7

Pitfall 4: Relying on Single Normal Troponin

• Normal cardiac enzymes do not exclude myocarditis; comprehensive evaluation (serial biomarkers, imaging, clinical picture) is essential. 7

Pitfall 5: Confusing Myopericarditis with Isolated Myocarditis

• Myopericarditis (pericarditis-predominant) has excellent prognosis and does not require steroids; treat with NSAIDs and colchicine instead. 1, 2
• Isolated myocarditis without pericardial involvement should not receive steroids unless it is a specific immune-mediated form. 2, 3

---

Prognosis Considerations

• Approximately 75% of patients admitted with myocarditis have an uncomplicated course with 0% mortality. 6
• Acute myocarditis complicated by heart failure or ventricular arrhythmias has a 12% rate of in-hospital mortality or need for heart transplant. 6
• Fulminant myocarditis with hemodynamic instability requiring mechanical support has approximately 28% mortality or heart transplant rate at 60 days. 6
• Myopericarditis has no evolution to heart failure or mortality in observational series. 2